Reliability and Validation of 3-D Electromagnetic Tracking During Pelvic Floor Muscle (PFM) Activation - a Pilot Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01590927|
Recruitment Status : Unknown
Verified May 2012 by Helene Moser, Moser, Helene.
Recruitment status was: Not yet recruiting
First Posted : May 3, 2012
Last Update Posted : May 3, 2012
|Condition or disease|
|Pelvic Floor Dyssynergia|
There will be two measurements. One measurement of MVIC and quick flicks will be done in a standing and supine position with 3 repetitions. The TrakSTARTM, Ultrasound, surface EMG and Accelerometer will measure the PFM movements and activation simultaneously. The Ultrasound is measured from one tester (to guaranty a high intratester reliability) (Sherburn et al., 2005).
TrakSTARTM, surface EMG and Accelerometer will measure 3 Trampoline jumps. The measurements will be done once during one hour. The women will insert the vaginal probe by themselves and stay dressed during the measurement procedure. The measurements will be done in a standardized way. All the arrangements are made to ensure the hygiene requirements.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Reliability and Validation of 3-D Electromagnetic Tracking During Pelvic Floor Muscle (PFM) Activation - a Pilot Study|
|Study Start Date :||August 2012|
|Estimated Primary Completion Date :||February 2013|
|Estimated Study Completion Date :||May 2013|
|20 healthy women|
- the way in x-y coordinates for the pelvic floor mouvement measured by the ultrasonography and TrakSTAR [ Time Frame: one year ]the mouvement of the pelvic floor is measured similtanous by the ultrasound and the TrakSTAR
- EMG [ Time Frame: one year ]EMG will measure the contraction of the plevic floor
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01590927
|Contact: Helene Moser, Msc in firstname.lastname@example.org|
|Inselspital||Not yet recruiting|
|Bern, Switzerland, 3010|
|Contact: Helene Moser, MSc in study 0041787752118 email@example.com|
|Study Chair:||Lorenz Radlinger, PhD||Berner Fachhochschule Gesundheit, Bern, Switzerland|